Sensitivity Pattern in Children Respiratory Bacterial Infections
Respiratory bacterial infections in children and sensitivity of antibiotics
DOI:
https://doi.org/10.56101/rimj.v4i2.161Keywords:
Gram-negative bacteria, Gram-positive bacteria, Respiratory infections, Antibiotic resistance, Acinetobacter baumannii, Streptococcus pneumoniae, Pneumonia, Antibiogram, Seasonal variationAbstract
Background: Bacterial respiratory infections are a major health concern, especially in underdeveloped and developing countries. This study aims to evaluate the prevalence of Gram-negative and Gram-positive bacteria in respiratory infections and assess the efficacy of antibiotics.
Methods: A prospective, observational study was conducted from July 2010 to July 2011. Patients with respiratory infections were categorized by age, bacterial pathogen, disease type, and season of infection. Diagnostic methods, including throat swabs, blood cultures, and antibiograms, were used to identify pathogens and determine antibiotic resistance profiles. The infection rate was calculated using standard epidemiological formulas.
Results: Gram-negative bacteria accounted for 84.7% of infections, with Acinetobacter baumannii (26.4%) being the most common pathogen. Gram-positive infections, primarily caused by Streptococcus pneumoniae (77%), were also prevalent. The highest infection rates were observed in the spring, particularly among children under one year and those aged 1-6 years. Pneumonia was the most common diagnosis (43.5%). Ampicillin resistance was widespread, but Acinetobacter baumannii, E. coli, and Klebsiella pneumoniae showed sensitivity to Sulbactam, Cefoperazone, and Piperacillin/Tazobactam.
Conclusion: Acinetobacter baumannii was the predominant cause of respiratory infections, especially in young children and during spring. Ampicillin resistance was common, but Sulbactam, Cefoperazone, and Piperacillin/Tazobactam were more effective. These findings highlight the importance of targeted antibiotic therapy, particularly for Gram-negative bacterial infections.
References
Al Dabbagh M, Alghounaim M, Almaghrabi RH, Dbaibo G, Ghatasheh G, Ibrahim HM, Aziz MA, Hassanien A, Mohamed N. A narrative review of healthcare-associated Gram-negative infections among pediatric patients in middle eastern countries. Infectious Diseases and Therapy. 2023 May;12(5):1217-35.
Al-Hasan MN, Huskins WC, Lahr BD, Eckel-Passow JE, Baddour LM. Epidemiology and outcome of Gram-negative bloodstream infection in children: a population-based study. Epidemiology & Infection. 2011 May;139(5):791-6.
Asempa TE, Nicolau DP, Kuti JL. In vitro activity of imipenem-relebactam alone or in combination with amikacin or colistin against Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy. 2019 Sep;63(9):10-128.
Bassem Abou Merhi MD. Research Article Urinary Tract Infection Extended Spectrum β Lactamase (ESBL) in Pediatric Patients: Mono-centric Hospital Study in Lebanon between 2012 and 2017.
Edwards T, Heinz E, van Aartsen J, Howard A, Roberts P, Corless C, Fraser AJ, Williams CT, Bulgasim I, Cuevas LE, Parry CM. Piperacillin/tazobactam-resistant, cephalosporin-susceptible Escherichia coli bloodstream infections are driven by multiple acquisition of resistance across diverse sequence types. Microbial Genomics. 2022 Apr 11;8(4):000789.
Jethwani U, Trivedi P, Shah N. Antibiotic Sensitivity Pattern of Gram Negative Bacilli Isolated from the Lower Respiratory Tract of Ventilated Patients in the Intensive Care Unit.
Kahlmeter G, Poulsen HO. Antimicrobial susceptibility of Escherichia coli from community-acquired urinary tract infections in Europe: the ECO· SENS study revisited. International journal of antimicrobial agents. 2012 Jan 1;39(1):45-51.
Kahlmeter G, Åhman J, Matuschek E. Antimicrobial resistance of Escherichia coli causing uncomplicated urinary tract infections: a European update for 2014 and comparison with 2000 and 2008. Infectious diseases and therapy. 2015 Dec;4:417-23.
Kito Y, Kuwabara K, Ono K, Kato K, Yokoi T, Horiguchi K, Kato K, Hirose M, Ohara T, Goto K, Nakamura Y. Seasonal variation in the prevalence of Gram-negative bacilli in sputum and urine specimens from outpatients and inpatients. Fujita medical journal. 2022;8(2):46-51.
Kritsotakis EI, Groves-Kozhageldiyeva A. A systematic review of the global seasonality of infections caused by Acinetobacter species in hospitalized patients. Clinical Microbiology and Infection. 2020 May 1;26(5):553-62.
Lake JG, Weiner LM, Milstone AM, Saiman L, Magill SS, See I. Pathogen distribution and antimicrobial resistance among pediatric healthcare-associated infections reported to the National Healthcare Safety Network, 2011–2014. infection control & hospital epidemiology. 2018 Jan;39(1):1-1.
Liu X, Qin P, Wen H, Wang W, Zhao J. Seasonal meropenem resistance in Acinetobacter baumannii and influence of temperature-driven adaptation. BMC microbiology. 2024 Apr 27;24(1):149.
Mermel LA, Machan JT, Parenteau S. Seasonality of MRSA infections. PloS one. 2011 Mar 23;6(3):e17925.
Navon-Venezia S, Kondratyeva K, Carattoli A. Klebsiella pneumoniae: a major worldwide source and shuttle for antibiotic resistance. FEMS microbiology reviews. 2017 May 1;41(3):252-75.
Shah PS, Yoon W, Kalapesi Z, Bassil K, Dunn M, Lee SK. Seasonal variations in healthcare-associated infection in neonates in Canada. Archives of Disease in Childhood-Fetal and Neonatal Edition. 2013 Jan 1;98(1):F65-9.
Sharma N, Thapa B, Acharya A, Raghubanshi BR. Meropenem Resistance among Acinetobacter Positive Clinical Samples in a Tertiary Care Centre in Nepal: A Descriptive Cross-sectional Study. JNMA: Journal of the Nepal Medical Association. 2021 Sep;59(241):853.
Shi T, Xie L. Distribution and antimicrobial resistance analysis of gram-negative bacilli isolated from a tertiary hospital in Central China: a 10-year retrospective study from 2012 to 2021. Frontiers in Microbiology. 2023 Dec 4;14:1297528.
Singh N, Puri S, Kumar S, Pahuja H, Kalia R, Arora R. Risk factors and outcome analysis of gram-positive bacteremia in critically ill patients. Cureus. 2023 Mar;15(3).
Tuon FF, Yamada CH, De Andrade AP, Arend LN, dos Santos Oliveira D, Telles JP. Oral doxycycline to carbapenem-resistant Acinetobacter baumannii infection as a polymyxin-sparing strategy: results from a retrospective cohort. Brazilian Journal of Microbiology. 2023 Sep;54(3):1795-802.
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Ahmad Bashir Mahboobi, Zarghoon Tareen, Sharafudin Resha, Bilal Ahmad Rahimi, Enayatullah Mohammadi
This work is licensed under a Creative Commons Attribution 4.0 International License.